Where does Hetero Labs Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hetero Labs Limited ranks #18,714 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hetero Labs Limited hold?

Hetero Labs Limited holds 15 US utility patents granted between 2018 and 2025, spanning 9 technology areas.

What is Hetero Labs Limited's Innovation Score?

Hetero Labs Limited has an Innovation Score of 26.5 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Hetero Labs Limited focus on?

Hetero Labs Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 12 patents, ranking #1,593 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Hetero Labs Limited's patent grant rate increasing or decreasing?

Hetero Labs Limited's recent grant velocity is +125% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Hetero Labs Limited's patents?

Hetero Labs Limited's patents average 8.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hetero Labs Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Hetero Labs Limited

USPTO PatentsView assignee record - 15 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hetero ranks #18,714 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 9 technology areas.

#18,714
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.5/100): 8.3
avg claims per patent: +125%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18714 · Foreign Corporation #18,714 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,714/49,997
PHOTO-FINISH Hangzhou Everich…
CPC-NARROW A61P · 9 areas
INNOV-THIN 26.5/100
CLAIMS-PAR 8.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +125% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hangzhou Everich Houseware Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hetero’s 26.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (36%) Velocity 1.3 pts (5%) Breadth 10.6 pts (40%) Claim depth 5.0 pts (19%)

Qualcomm Incorporated · highest

85
Hetero Labs · this assignee

26
3D Lighting… · lowest

7

What this shows Hetero's Innovation Score is 26.5/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hetero?

Each dot is one of Hetero’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hetero’s own 8.3 claims/patent is at or below the 11.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Hetero vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hetero's grants concentrate

Hetero Labs Limited is a focused PatentsView assignee: 9 CPC subclasses with 80% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2018. By volume, Hetero sits between Hangzhou Everich Houseware Co., Ltd. and Hitachi Zosen Inova AG.

Hetero's three-year grant acceleration

Hetero Labs Limited shows 2 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hangzhou Everich…

15
Hansol Chemical

15
Head-direct (Kuns…

15
Healthier Choices…

15
Heuft Systemtechn…

15
Hexagon Metrology…

15
Hisense Hiview Te…

15
Hitachi Zosen Ino…

15
Hetero Labs ◀

15

What this shows Hetero holds 15 patents at rank #18,700, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hetero

By rank, the assignees closest to #18,700 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Hetero's primary technology class.

Hetero's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Hetero Labs Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	6.7%
2019	3	20.0%
2020	4	26.7%
2021	3	20.0%
2022	1	6.7%
2023	1	6.7%
2025partial year	2	13.3%

Which technologies does Hetero Labs Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C07J - Steroids 7

C07D - Heterocyclic Compounds 6

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07C - Acyclic OR Carbocyclic Compounds 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hetero Labs Limited's patent record in context - here's where to go next.

Hetero Labs Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 80% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #18,714 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hetero Labs Limited against Hangzhou Everich Houseware Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.